Benzodiazepines (BZs) affect acquisition of new information, while ret
rieval of already learned information is unimpaired. The variability o
f this effect is important and depends on the nature of the BZ, its do
se, the route of administration and the susceptibility of the subject
taking the drug. This last factor depends itself on the anxiety level,
the age, and a less known idiosyncratic susceptibility of the patient
. Finally, there is probably a partial tolerance for the amnestic acti
on of BZs, which explains the fact that the most dramatic amnesias hav
e been described after administration of a single dose of BZ, taken by
a patient unaccustomed to BZs. The value of pharmacocinetic and pharm
acodynamic characteristics in predicting cognitive impairment remains
misunderstood, even though in clinical practice the greatest amnestic
effects have been described with short-acting BZs. The interest of stu
dying BZs induced amnesia rely upon several arguments: first, it can b
e an harmful side-effect, which could be avoided or at least predicted
by a better knowledge of BZs and the synthesis of new and more specif
ic drugs; secondly it is an interesting model of organic amnesia, whic
h could allow a better understanding of normal memory.